Franklin Street Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Franklin Street Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-56,330	Closed	-$422K	–	166
2021 Q4	$422K	Buy	56,330 +2,500	+5%	+$18.7K	0.03%	118
2021 Q3	$485K	Sell	53,830 -880	-2%	-$7.93K	0.04%	111
2021 Q2	$655K	Buy	54,710 +44,000	+411%	+$527K	0.06%	96
2021 Q1	$134K	Sell	10,710 -2,070	-16%	-$25.9K	0.01%	148
2020 Q4	$199K	Hold	12,780	–	–	0.02%	144
2020 Q3	$121K	Sell	12,780 -25,000	-66%	-$237K	0.01%	135
2020 Q2	$339K	Hold	37,780	–	–	0.04%	113
2020 Q1	$241K	Buy	37,780 +25,000	+196%	+$159K	0.04%	118
2019 Q4	$107K	Hold	12,780	–	–	0.01%	150
2019 Q3	$116K	Hold	12,780	–	–	0.01%	151
2019 Q2	$138K	Buy	12,780 +880	+7%	+$9.5K	0.02%	153
2019 Q1	$114K	Hold	11,900	–	–	0.02%	149
2018 Q4	$137K	Sell	11,900 -29,000	-71%	-$334K	0.02%	139
2018 Q3	$693K	Sell	40,900 -500	-1%	-$8.47K	0.09%	88
2018 Q2	$588K	Buy	41,400 +1,000	+2%	+$14.2K	0.09%	92
2018 Q1	$768K	Sell	40,400 -5,800	-13%	-$110K	0.12%	87
2017 Q4	$758K	Sell	46,200 -10,300	-18%	-$169K	0.11%	92
2017 Q3	$848K	Hold	56,500	–	–	0.14%	87
2017 Q2	$497K	Sell	56,500 -20,000	-26%	-$176K	0.09%	99
2017 Q1	$398K	Buy	+76,500	New	+$398K	0.07%	118
2016 Q4	–	Sell	-11,000	Closed	-$51K	–	178
2016 Q3	$51K	Sell	11,000 -42,500	-79%	-$197K	0.01%	177
2016 Q2	$310K	Hold	53,500	–	–	0.06%	156
2016 Q1	$324K	Hold	53,500	–	–	0.06%	170
2015 Q4	$489K	Sell	53,500 -2,500	-4%	-$22.9K	0.1%	142
2015 Q3	$316K	Hold	56,000	–	–	0.06%	175
2015 Q2	$621K	Hold	56,000	–	–	0.11%	137
2015 Q1	$878K	Sell	56,000 -30,000	-35%	-$470K	0.16%	117
2014 Q4	$1.31M	Hold	86,000	–	–	0.25%	97
2014 Q3	$928K	Sell	86,000 -18,750	-18%	-$202K	0.18%	115
2014 Q2	$1.6M	Sell	104,750 -40,900	-28%	-$624K	0.31%	77
2014 Q1	$2.63M	Buy	145,650 +650	+0.4%	+$11.8K	0.53%	55
2013 Q4	$2.01M	Sell	145,000 -4,800	-3%	-$66.7K	0.41%	72
2013 Q3	$1.57M	Buy	149,800 +28,000	+23%	+$294K	0.35%	78
2013 Q2	$951K	Buy	+121,800	New	+$951K	0.23%	116